Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04782713 · ClinicalTrials.gov registry record · NA

Smart Prostate Specific Antigen (PSA) Screening Study

A NA study of Prostate Cancer and PSA, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
49
Enrollment target
1
Study location

NCT04782713 is a NA study of Prostate Cancer and PSA that has completed, run by University of Illinois at Chicago. The registered enrollment target is 49 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04782713, a NA study of Prostate Cancer and PSA, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target
1
Study location

Study Summary

This intervention includes the introduction of the Prostate Cancer Working Group (PCWG )Smart PSA Screening Guidelines and implementation of patient navigation/ care coordination for men with elevated PSA (\>4.0 ng/mL). The guidelines include: 1. What age to start? 2. How often to repeat screening? 3. What age to stop? 4. What PSA threshold should trigger a biopsy referral?

Conditions Studied

Prostate Cancer PSA

Interventions

  • OTHER Completing surveys

Study Locations (1)

Illinois

  • Mile Square Health Center - Chicago

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2021-12-17
Est. Completion 2024-11-15
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04782713

The ClinicalTrials.gov registry entry for NCT04782713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Completing surveys is the first listed.

NCT04782713 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04782713 about?

NCT04782713 is a clinical study titled "Smart Prostate Specific Antigen (PSA) Screening Study". This intervention includes the introduction of the Prostate Cancer Working Group (PCWG )Smart PSA Screening Guidelines and implementation of patient navigation/ care coordination for men with elevated PSA (\>4.0 ng/mL). The guidelines include: 1. What age to start? 2. How often to repeat screening...

What is the current status of trial NCT04782713?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2021-12-17. Estimated completion is 2024-11-15.

What conditions does trial NCT04782713 study?

This clinical trial studies the following conditions: Prostate Cancer, PSA.

What interventions are being tested in trial NCT04782713?

The interventions under investigation include: Completing surveys (OTHER).

Who is sponsoring clinical trial NCT04782713?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04782713 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

PSA

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.